Search research articles
Contact Us
Filters
Showing results (51-60 of 81) with videos related to
Page
of 9
Sort By:
Presse Medicale (Paris, France : 1983)
|
July 6, 1996
[Prescription of diphosphonates in ambulatory oncology. A study of the health insurance medical services]
C Vicrey, J F Bayet, J M Extra, et al.
Bulletin Du Cancer
|
November 1, 1993
[Promising results of bimonthly chemotherapy with high dose cyclophosphamide and epirubicin in induction treatment of inflammatory cancer of the breast]
S Culine, J M Extra, M Espie, et al.
La Revue De Medecine Interne
|
May 5, 2000
[Retrospective multivariate analysis of radio-pathological correlations of nonpalpable breast lesions. Experience of the Hospital Saint-Louis]
P H Cottu, I Cojean-Zelek, E Bourstyn, et al.
Journal of Hematotherapy & Stem Cell Research
|
January 19, 2002
Residual tumor cell contamination in peripheral blood stem cells collections of 117 breast cancer patients evaluated by immunocytochemical technique
L Dal Cortivo, P H Cottu, J P Lotz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 1997
High dose-intensity of irinotecan administered every 3 weeks in advanced cancer patients: a feasibility study
Y Merrouche, J M Extra, D Abigerges, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 26, 1999
Oxaliplatin and paclitaxel combination in patients with platinum-pretreated ovarian carcinoma: an investigator-originated compassionate-use experience
S Faivre, S Kalla, E Cvitkovic, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 1986
Intensive and sequential combination chemotherapy for aggressive malignant lymphomas (protocol LNH-80)
B Coiffier, P A Bryon, F Berger, et al.
Bulletin Du Cancer
|
January 1, 1992
[Esophageal cancer: did combined treatments improve prognosis?]
G Ganem, Y Raoul, M J Goudier, et al.
British Journal of Cancer
|
June 1, 1994
p53 mutations and overexpression in locally advanced breast cancers
A Faille, P De Cremoux, J M Extra, et al.
Cancer Research
|
August 15, 1994
Phase I and pharmacokinetic study of the camptothecin derivative irinotecan, administered on a weekly schedule in cancer patients
M de Forni, R Bugat, G G Chabot, et al.
Page
of 9
Search research articles
Search
Showing results (51-60 of 81) with videos related to
Sort By:
Page
of 9
Presse Medicale (Paris, France : 1983)
|
July 6, 1996
[Prescription of diphosphonates in ambulatory oncology. A study of the health insurance medical services]
C Vicrey, J F Bayet, J M Extra, et al.
Bulletin Du Cancer
|
November 1, 1993
[Promising results of bimonthly chemotherapy with high dose cyclophosphamide and epirubicin in induction treatment of inflammatory cancer of the breast]
S Culine, J M Extra, M Espie, et al.
La Revue De Medecine Interne
|
May 5, 2000
[Retrospective multivariate analysis of radio-pathological correlations of nonpalpable breast lesions. Experience of the Hospital Saint-Louis]
P H Cottu, I Cojean-Zelek, E Bourstyn, et al.
Journal of Hematotherapy & Stem Cell Research
|
January 19, 2002
Residual tumor cell contamination in peripheral blood stem cells collections of 117 breast cancer patients evaluated by immunocytochemical technique
L Dal Cortivo, P H Cottu, J P Lotz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 1997
High dose-intensity of irinotecan administered every 3 weeks in advanced cancer patients: a feasibility study
Y Merrouche, J M Extra, D Abigerges, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 26, 1999
Oxaliplatin and paclitaxel combination in patients with platinum-pretreated ovarian carcinoma: an investigator-originated compassionate-use experience
S Faivre, S Kalla, E Cvitkovic, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 1986
Intensive and sequential combination chemotherapy for aggressive malignant lymphomas (protocol LNH-80)
B Coiffier, P A Bryon, F Berger, et al.
Bulletin Du Cancer
|
January 1, 1992
[Esophageal cancer: did combined treatments improve prognosis?]
G Ganem, Y Raoul, M J Goudier, et al.
British Journal of Cancer
|
June 1, 1994
p53 mutations and overexpression in locally advanced breast cancers
A Faille, P De Cremoux, J M Extra, et al.
Cancer Research
|
August 15, 1994
Phase I and pharmacokinetic study of the camptothecin derivative irinotecan, administered on a weekly schedule in cancer patients
M de Forni, R Bugat, G G Chabot, et al.
Page
of 9